http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10064402-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a47c84dd24a3b6ac58e5c33f3609504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca88218d1b3d473097e26aa9fef933d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d552d820b5c9f2ee033a8126927f9cfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b40ec282fdbe5b83c9c34560563abd42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56c1cf180ba3a81c7ad2ae7894980363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc468705cefd875b12f83daec44630e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15546743ab77b64c2b1a22ec4b61c61c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df3e52767916f8c9bca9791bd5f7afb
publicationDate 2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-10064402-A1
titleOfInvention Diphenylazetidinone derivatives, processes for their preparation, medicaments containing these compounds and their use
abstract The invention relates to compounds of the formula I, DOLLAR F1 in which R1, R2, R3, R4, R5 and R6 have the meanings indicated, and to their physiologically tolerable salts. The compounds are suitable for. B. as hypolipidemics.
priorityDate 2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419966142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412961548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15922486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15922485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410571875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22252043

Total number of triples: 53.